Timolol 0.5%

DRUG9 trials

Conditions

GlaucomaGlaucoma Open-Angle PrimaryGlaucoma, Open-AngleGlaucoma, Primary Open AngleOcular HypertensionOpen-Angle GlaucomaPrimary Open-Angle Glaucoma

Phase 1

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

CompletedNCT02742649

ForSight Vision5, Inc.Ocular Hypertension, Open-Angle Glaucoma

Start: 2016-04-30End: 2016-12-31Updated: 2019-02-25

Safety and IOP-Lowering Effects of WB007

CompletedNCT04149899

Bausch & Lomb IncorporatedGlaucoma, Primary Open Angle, Ocular Hypertension

Start: 2019-11-14End: 2022-12-14Updated: 2025-03-27

Phase 2

A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma

CompletedNCT00991822

Medical University of ViennaGlaucoma, Open-Angle

Start: 1999-05-31End: 2003-12-31Updated: 2009-10-08

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

CompletedNCT01915940

ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma

Start: 2013-10-23End: 2014-11-14Updated: 2018-04-20

Dose-Ranging Study of the Bimatoprost Ocular Insert

CompletedNCT02358369

ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma

Start: 2015-01-19End: 2015-10-07Updated: 2020-06-04

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

CompletedNCT05913232

D. Western Therapeutics Institute, Inc.Glaucoma Open-Angle Primary, Ocular Hypertension

Start: 2023-08-28End: 2024-08-29Updated: 2025-08-27

Phase 3

A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

CompletedNCT00800267

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Glaucoma, Ocular Hypertension

Start: 1997-07-31End: 1999-06-30Updated: 2021-02-18

Phase 4

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT01881126

AllerganGlaucoma, Ocular Hypertension

Start: 2013-06-30End: 2014-10-31Updated: 2015-11-30

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT02097719

AllerganGlaucoma, Ocular Hypertension

Start: 2014-05-31End: 2014-12-31Updated: 2016-01-14

Related Papers

Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.

2022-12-0130 citations

Effect of dorzolamide and timolol on ocular pressure: blood flow relationship in patients with primary open-angle glaucoma and ocular hypertension.

2009-10-2226 citations